GlassScriptPhysician profile
Joseph P Rogers
NPI 1467783712
$1,229.92
in general payments reported to CMS, 2019-2025
19 companies · $27.79 in 2025
The $27.79 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $105 · 2021: $132 · 2022: $319 · 2023: $170 · 2024: $159 · 2025: $27.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $397.49 | 2021-2024 | Nuzyra |
| Smith+Nephew, INC. | $252.88 | 2019-2022 | |
| Next Science LLC | $79.17 | 2023-2024 | Surgx, Xperience, Blastx |
| Kci USA, INC. | $57.15 | 2023 | Promogran Prisma, Tegaderm, Activ.A.C. Ion Progress |
| Grt US Holding, INC. | $49.57 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $45.04 | 2019 | |
| Alfasigma USA, INC. | $42.90 | 2020 | |
| Medtronic, INC. | $40.59 | 2023-2024 | Intellis Adaptivestim, Closurefast |
| Convatec INC. | $34.24 | 2019-2020 | |
| Reprise Biomedical, INC. | $33.17 | 2024 | Miro3d |
| Stryker Corporation | $31.24 | 2019 | |
| Averitas Pharma INC. | $27.83 | 2023 | Qutenza |
| Djo, LLC | $27.79 | 2025 | Cmf |
| Organogenesis INC. | $25.86 | 2019 | |
| Amgen INC. | $23.42 | 2024 | Krystexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.49 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.39 | 2023 | Seglentis |
| Melinta Therapeutics, LLC | $14.86 | 2019 | |
| Nabriva Therapeutics, Plc | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.